CureVac N.V. (CVAC)
USD 3.56
(4.71%)
USD 3.56
(4.71%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 271.53 Million EUR | -17.02% |
| 2022 | 327.21 Million EUR | -30.34% |
| 2021 | 469.76 Million EUR | -41.28% |
| 2020 | 800 Million EUR | 361.31% |
| 2019 | 173.42 Million EUR | 85.33% |
| 2018 | 93.57 Million EUR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 243.51 Million EUR | -10.32% |
| 2024 Q2 | 180.4 Million EUR | -25.96% |
| 2023 Q2 | 250.43 Million EUR | -3.78% |
| 2023 Q1 | 260.27 Million USD | -20.46% |
| 2023 FY | 271.53 Million EUR | -17.02% |
| 2023 Q4 | 271.53 Million EUR | 13.0% |
| 2023 Q3 | 240.3 Million EUR | -4.05% |
| 2022 Q2 | 302.61 Million EUR | -13.98% |
| 2022 FY | 327.21 Million EUR | -30.34% |
| 2022 Q4 | 327.21 Million EUR | 14.6% |
| 2022 Q3 | 285.52 Million EUR | -5.65% |
| 2022 Q1 | 351.79 Million EUR | -25.11% |
| 2021 Q2 | 965.72 Million EUR | 0.0% |
| 2021 FY | 469.76 Million EUR | -41.28% |
| 2021 Q1 | - EUR | -100.0% |
| 2021 Q4 | 469.76 Million EUR | -51.46% |
| 2021 Q3 | 967.83 Million EUR | 0.22% |
| 2020 Q4 | 800 Million EUR | 207.04% |
| 2020 Q2 | - EUR | -100.0% |
| 2020 Q3 | 260.55 Million EUR | 0.0% |
| 2020 Q1 | 199.31 Million EUR | 14.93% |
| 2020 FY | 800 Million EUR | 361.31% |
| 2019 Q1 | - EUR | 0.0% |
| 2019 FY | 173.42 Million EUR | 85.33% |
| 2019 Q4 | 173.42 Million EUR | 0.0% |
| 2018 FY | 93.57 Million EUR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Absci Corporation | 58.3 Million USD | -365.717% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | 23.047% |
| Alnylam Pharmaceuticals, Inc. | 4.05 Billion USD | 93.296% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -8317.57% |
| Apollomics, Inc. | 14.15 Million USD | -1818.545% |
| 180 Life Sciences Corp. | 5.38 Million USD | -4940.304% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -5085.861% |
| Bicycle Therapeutics plc | 224.41 Million USD | -20.997% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -886.993% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -108.534% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -431.342% |
| Chimerix, Inc. | 19.74 Million USD | -1275.192% |
| CRISPR Therapeutics AG | 346.76 Million USD | 21.696% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | -36.915% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -205.569% |
| Fortress Biotech, Inc. | 165.93 Million USD | -63.633% |
| Fortress Biotech, Inc. | 165.93 Million USD | -63.633% |
| Gritstone bio, Inc. | 125.91 Million USD | -115.64% |
| Allakos Inc. | 74.79 Million USD | -263.044% |
| Boundless Bio, Inc. Common Stock | 256.97 Million USD | -5.664% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -294.903% |
| Cytokinetics, Incorporated | 1.21 Billion USD | 77.571% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -1776.126% |
| Innoviva, Inc. | 568.55 Million USD | 52.242% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -38416.061% |
| NLS Pharmaceutics AG | 10.68 Million USD | -2442.383% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -932.675% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -20799.255% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -1964.88% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -1003.518% |
| ImmuCell Corporation | 18.81 Million USD | -1343.164% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -861.991% |
| Incyte Corporation | 1.59 Billion USD | 82.947% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -388.408% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -67126.122% |
| Mustang Bio, Inc. | 17.61 Million USD | -1441.13% |
| MiMedx Group, Inc. | 96.33 Million USD | -181.877% |
| MEI Pharma, Inc. | 8.35 Million USD | -3149.93% |
| MacroGenics, Inc. | 154.2 Million USD | -76.083% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -15350.823% |
| Mereo BioPharma Group plc | 15.96 Million USD | -1601.113% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -8730.735% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -76.156% |
| Maravai LifeSciences Holdings, Inc. | 697.56 Million USD | 61.074% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -218.109% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -4354.26% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -5276.865% |
| NextCure, Inc. | 14.99 Million USD | -1710.573% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -899.417% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -6617.756% |
| Onconetix, Inc. | 23.18 Million USD | -1071.36% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -3966.672% |
| Opthea Limited | 264.6 Million USD | -2.619% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -382.896% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -2143.192% |
| PDS Biotechnology Corporation | 33.25 Million USD | -716.412% |
| Precigen, Inc. | 41.64 Million USD | -552.031% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -2177.568% |
| Prime Medicine, Inc. | 60.78 Million USD | -346.745% |
| PureTech Health plc | 125.58 Million USD | -116.217% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -268.094% |
| Regeneron Pharmaceuticals, Inc. | 7.1 Billion USD | 96.179% |
| Replimune Group, Inc. | 113.21 Million USD | -139.839% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -4779.369% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -86.148% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -7594.542% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | -3.481% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -4009.584% |
| Sesen Bio, Inc. | 30.98 Million USD | -776.361% |
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -229.397% |
| Solid Biosciences Inc. | 38.45 Million USD | -606.047% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -362.701% |
| SciSparc Ltd. | 1.59 Million USD | -16923.93% |
| Sutro Biopharma, Inc. | 321.08 Million USD | 15.434% |
| TG Therapeutics, Inc. | 169.08 Million USD | -60.589% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -454.916% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -18704.133% |
| Travere Therapeutics, Inc. | 588.1 Million USD | 53.829% |
| UroGen Pharma Ltd. | 243.52 Million USD | -11.501% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -339.13% |
| XOMA Corporation | 145.58 Million USD | -86.517% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -117.86% |
| AbCellera Biologics Inc. | 335.77 Million USD | 19.133% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -2678.102% |
| Cassava Sciences, Inc. | 14.19 Million USD | -1812.869% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -671.899% |
| Precision BioSciences, Inc. | 140.92 Million USD | -92.685% |
| Dyadic International, Inc. | 2.34 Million USD | -11500.691% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -6469.845% |
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -1569.629% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -2933.874% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -773.345% |
| IGM Biosciences, Inc. | 220.17 Million USD | -23.324% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -182.378% |
| Acelyrin, Inc. | 86.35 Million USD | -214.444% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -452.163% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -107.741% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -7594.895% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -79.955% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -79.215% |
| Senti Biosciences, Inc. | 52.57 Million USD | -416.505% |
| Mesoblast Limited | 188.79 Million USD | -43.821% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | -50.193% |
| ChromaDex Corporation | 26.5 Million USD | -924.339% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -3073.14% |
| Akebia Therapeutics, Inc. | 272.28 Million USD | 0.277% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -16623.886% |
| Seer, Inc. | 39.36 Million USD | -589.779% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | 21.879% |
| Novavax, Inc. | 2.57 Billion USD | 89.444% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -3429.124% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -97.048% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -1373.713% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -185.591% |
| Celcuity Inc. | 51.45 Million USD | -427.758% |
| ContextLogic Inc. | 206 Million USD | -31.811% |
| Phathom Pharmaceuticals, Inc. | 486.6 Million USD | 44.198% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -279.871% |
| Jazz Pharmaceuticals plc | 7.65 Billion USD | 96.454% |
| Amarin Corporation plc | 279.58 Million USD | 2.881% |
| AnaptysBio, Inc. | 364.28 Million USD | 25.462% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -2051.428% |
| Aptorum Group Limited | 5.25 Million USD | -5065.403% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | 63.564% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | 43.241% |
| Ardelyx, Inc. | 130.76 Million USD | -107.652% |
| Celularity Inc. | 102.92 Million USD | -163.805% |
| Omeros Corporation | 403.25 Million USD | 32.665% |
| Humacyte, Inc. | 114.67 Million USD | -136.78% |
| Immunocore Holdings plc | 228.15 Million USD | -19.01% |
| IO Biotech, Inc. | 17.55 Million USD | -1446.66% |
| GT Biopharma, Inc. | 6.63 Million USD | -3993.648% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -1455.877% |
| Summit Therapeutics Inc. | 125.25 Million USD | -116.78% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -13781.988% |
| Pulmatrix, Inc. | 15.96 Million USD | -1601.007% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | -8.263% |
| Evogene Ltd. | 17.99 Million USD | -1409.348% |
| CorMedix Inc. | 11.91 Million USD | -2178.423% |
| BioLineRx Ltd. | 50.7 Million USD | -435.544% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -2798.812% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -4702.471% |
| PTC Therapeutics, Inc. | 2.72 Billion USD | 90.024% |
| scPharmaceuticals Inc. | 57.26 Million USD | -374.2% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -1106.754% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -136.501% |
| NLS Pharmaceutics AG | 10.68 Million USD | -2442.383% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -4009.584% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -503.873% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -9361.034% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -3893.113% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -294.8% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -1342.323% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -480.953% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -2091.889% |
| Daré Bioscience, Inc. | 26.32 Million USD | -931.269% |
| bluebird bio, Inc. | 424.62 Million USD | 36.054% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | 85.634% |
| DBV Technologies S.A. | 42.8 Million USD | -534.42% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -112.481% |
| Galecto, Inc. | 5.89 Million USD | -4505.354% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -2764.56% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -889.655% |
| Inhibrx Biosciences, Inc. | 264.39 Million USD | -2.701% |
| GlycoMimetics, Inc. | 6.9 Million USD | -3834.059% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | -7.453% |
| ADMA Biologics, Inc. | 193.97 Million USD | -39.982% |
| Clene Inc. | 38.95 Million USD | -597.111% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | -42.714% |
| Aptose Biosciences Inc. | 15.8 Million USD | -1617.609% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -2359.596% |
| Soligenix, Inc. | 7.27 Million USD | -3632.444% |
| Century Therapeutics, Inc. | 175.94 Million USD | -54.331% |
| Kura Oncology, Inc. | 51.66 Million USD | -425.593% |
| Surrozen, Inc. | 8.14 Million USD | -3233.722% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -123.885% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -4005.498% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | -7.496% |
| Autolus Therapeutics plc | 263.9 Million USD | -2.889% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -2490.457% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -478.971% |
| Caribou Biosciences, Inc. | 72.56 Million USD | -274.181% |
| GRI Bio, Inc. | 2.69 Million USD | -9967.916% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -33439.614% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -653.041% |
| INmune Bio, Inc. | 18.86 Million USD | -1339.57% |
| Heron Therapeutics, Inc. | 256.47 Million USD | -5.869% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -919.194% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -9888.636% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -7470.896% |
| Jaguar Health, Inc. | 45.86 Million USD | -492.011% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -8177.734% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -364.514% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -443.825% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | -2.567% |
| Coherus BioSciences, Inc. | 823.02 Million USD | 67.008% |
| Verastem, Inc. | 71.18 Million USD | -281.445% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -603.851% |
| Histogen Inc. | 5.69 Million USD | -4666.222% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -6091.43% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | 14.398% |
| Surrozen, Inc. | 8.14 Million USD | -3233.722% |
| Organovo Holdings, Inc. | 2.74 Million USD | -9781.066% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -86414.183% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -32738.299% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -114.268% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -2411.023% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -10314.106% |
| Kronos Bio, Inc. | 54.2 Million USD | -400.972% |
| Turnstone Biologics Corp. | 14.14 Million USD | -1819.223% |
| Synaptogenix, Inc. | 5.52 Million USD | -4810.629% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -3984.412% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | -19.706% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -59.623% |
| Exelixis, Inc. | 678.44 Million USD | 59.977% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -65.522% |
| Apellis Pharmaceuticals, Inc. | 594.2 Million USD | 54.304% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -1750.175% |
| ESSA Pharma Inc. | 3.49 Million USD | -7668.989% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -5236.05% |
| Avid Bioservices, Inc. | 275.66 Million USD | 1.5% |
| Insmed Incorporated | 1.66 Billion USD | 83.66% |
| MediWound Ltd. | 27.18 Million USD | -898.756% |
| OmniAb, Inc. | 87.4 Million USD | -210.677% |
| Alector, Inc. | 487.66 Million USD | 44.32% |
| Seres Therapeutics, Inc. | 403.45 Million USD | 32.699% |
| Zai Lab Limited | 240.17 Million USD | -13.055% |
| AlloVir, Inc. | 45.01 Million USD | -503.203% |
| Revance Therapeutics, Inc. | 630.05 Million USD | 56.904% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -787.416% |
| Aura Biosciences, Inc. | 29.22 Million USD | -829.044% |
| Immunic, Inc. | 25.36 Million USD | -970.371% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -292.183% |
| Veracyte, Inc. | 93.71 Million USD | -189.73% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -10276.982% |
| FibroGen, Inc. | 585.72 Million USD | 53.642% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -1462.053% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -223.152% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -41477.349% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -4701.232% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -3212.17% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -223.167% |
| Fortrea Holdings Inc. | 2.61 Billion USD | 89.63% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -842.099% |
| XBiotech Inc. | 8.39 Million USD | -3133.675% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -1750.175% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -618.11% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -1788.391% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -410.59% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | 25.22% |
| Agenus Inc. | 462.29 Million USD | 41.264% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -910.012% |
| Theravance Biopharma, Inc. | 169 Million USD | -60.666% |
| Ultragenyx Pharmaceutical Inc. | 1.21 Billion USD | 77.663% |
| Metagenomi, Inc. Common Stock | 500.42 Million USD | 45.74% |
| BioCryst Pharmaceuticals, Inc. | 972.48 Million USD | 72.079% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -4402.186% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -108.33% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -73011.489% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -5168.337% |
| Lantern Pharma Inc. | 2.73 Million USD | -9811.066% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -539.274% |
| Ainos, Inc. | 7.39 Million USD | -3572.214% |
| Pluri Inc. | 34.11 Million USD | -696.0% |
| Prothena Corporation plc | 135.01 Million USD | -101.109% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | -11.694% |
| Rallybio Corporation | 9.43 Million USD | -2777.614% |
| Kodiak Sciences Inc. | 213.59 Million USD | -27.127% |
| Cue Biopharma, Inc. | 24.44 Million USD | -1010.786% |
| MeiraGTx Holdings plc | 319.99 Million USD | 15.144% |
| Annexon, Inc. | 47.11 Million USD | -476.28% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -181.754% |
| Moderna, Inc. | 4.57 Billion USD | 94.061% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -5469.881% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -253.833% |
| Blueprint Medicines Corporation | 918.64 Million USD | 70.442% |
| Immix Biopharma, Inc. | 3.72 Million USD | -7195.742% |
| CalciMedica, Inc. | 4.02 Million USD | -6641.104% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -118.089% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -216.408% |
| Wave Life Sciences Ltd. | 227.44 Million USD | -19.383% |
| Sana Biotechnology, Inc. | 277.79 Million USD | 2.254% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -1621.497% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -434.658% |
| Nutriband Inc. | 1.07 Million USD | -25067.013% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -2453.67% |
| Vor Biopharma Inc. | 59.1 Million USD | -359.413% |
| Roivant Sciences Ltd. | 773.95 Million USD | 64.916% |
| Alkermes plc | 933.53 Million USD | 70.914% |
| ProKidney Corp. | 29.21 Million USD | -829.394% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -277.237% |
| Arcellx, Inc. | 339.75 Million USD | 20.079% |
| BridgeBio Pharma, Inc. | 1.88 Billion USD | 85.625% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -81.676% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -207.02% |
| Atai Life Sciences N.V. | 49.16 Million USD | -452.32% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -771.626% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -1411.701% |
| MediciNova, Inc. | 3.89 Million USD | -6877.463% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -1385.484% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -17951.076% |
| GeoVax Labs, Inc. | 3.51 Million USD | -7614.229% |
| Axsome Therapeutics, Inc. | 397.25 Million USD | 31.649% |
| Biomea Fusion, Inc. | 30.69 Million USD | -784.756% |
| RenovoRx, Inc. | 4.46 Million USD | -5979.975% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -770.266% |
| Geron Corporation | 146.12 Million USD | -85.819% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -1325.513% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -746.896% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -267.979% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -210.382% |
| Royalty Pharma plc | 6.29 Billion USD | 95.688% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -704.062% |
| Imunon, Inc. | 8.53 Million USD | -3083.096% |
| BioAtla, Inc. | 48.98 Million USD | -454.305% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -107.905% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -1810.177% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | -43.549% |
| Structure Therapeutics Inc. | 29.05 Million USD | -834.672% |
| 89bio, Inc. | 59.96 Million USD | -352.832% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -706.57% |
| aTyr Pharma, Inc. | 31.59 Million USD | -759.359% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -339.208% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -460.993% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -3228.403% |
| Akari Therapeutics, Plc | 4.58 Million USD | -5823.466% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -1431.211% |
| Halozyme Therapeutics, Inc. | 1.64 Billion USD | 83.538% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -99.188% |
| Liquidia Corporation | 73.13 Million USD | -271.259% |
| Entera Bio Ltd. | 1.37 Million USD | -19590.478% |
| GH Research PLC | 6.7 Million USD | -3952.107% |
| Vericel Corporation | 127.7 Million USD | -112.624% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -607.427% |
| Xencor, Inc. | 283.55 Million USD | 4.242% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -8994.482% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -9888.636% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -7127.113% |
| Vaxcyte, Inc. | 167.44 Million USD | -62.158% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -636.317% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -162.273% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -67126.122% |
| Portage Biotech Inc. | 4.45 Million USD | -6001.836% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -17951.076% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -1078.012% |
| OncoCyte Corporation | 49.29 Million USD | -450.797% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -6463.802% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -33948.543% |
| Purple Biotech Ltd. | 10 Million USD | -2613.96% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -993.343% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -3987.486% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -66.598% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -4592.908% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -2135.933% |
| United Therapeutics Corporation | 1.18 Billion USD | 77.032% |
| HilleVax, Inc. | 78.9 Million USD | -244.107% |
| Silo Pharma, Inc. | 1.56 Million USD | -17203.057% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -20230.863% |
| Pharming Group N.V. | 244.07 Million USD | -11.25% |
| Tharimmune, Inc. | 1.81 Million USD | -14860.044% |
| Genprex, Inc. | 3.25 Million USD | -8244.017% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -1163.467% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -901.26% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -465.432% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -131711.498% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -75630.916% |
| OKYO Pharma Limited | 7.42 Million USD | -3559.039% |
| Savara Inc. | 37.19 Million USD | -630.081% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -835.832% |
| Curis, Inc. | 57.61 Million USD | -371.311% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -592.687% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -1204.249% |
| BeiGene, Ltd. | 2.23 Billion USD | 87.844% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -1176.355% |
| Erasca, Inc. | 78.61 Million USD | -245.412% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -41339.276% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -41339.276% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -3781.797% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -16296.841% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -1490.695% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -644.82% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -388.059% |
| Adicet Bio, Inc. | 37.12 Million USD | -631.497% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | 56.042% |
| Aditxt, Inc. | 28.53 Million USD | -851.689% |
| Adagene Inc. | 45.16 Million USD | -501.142% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -150165.735% |
| Quantum-Si incorporated | 26.63 Million USD | -919.608% |
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -8824.806% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -136.195% |
| Compugen Ltd. | 55.77 Million USD | -386.834% |
| Generation Bio Co. | 171.63 Million USD | -58.208% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -2250.924% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -549.116% |
| Invivyd, Inc. | 51.71 Million USD | -425.074% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -195.217% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -4074.039% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -259.664% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -26494.68% |
| 2seventy bio, Inc. | 310.12 Million USD | 12.445% |
| Instil Bio, Inc. | 99.8 Million USD | -172.073% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -651.481% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -19823.93% |
| GeoVax Labs, Inc. | 3.51 Million USD | -7614.229% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -2129.386% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -2126.619% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -413.866% |
| Vir Biotechnology, Inc. | 369.85 Million USD | 26.584% |
| Evaxion Biotech A/S | 17.61 Million USD | -1441.263% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -68.728% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -77.256% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -1157.382% |
| Cingulate Inc. | 10.36 Million USD | -2520.743% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -9773.879% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -628.123% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -992.727% |
| Clearmind Medicine Inc. | 3.61 Million USD | -7421.637% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -477.199% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -1093.036% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -1252.856% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | -15.44% |
| ImmunityBio, Inc. | 1.09 Billion USD | 75.098% |
| Korro Bio, Inc. | 51.75 Million USD | -424.679% |
| Kineta, Inc. | 7.22 Million USD | -3659.785% |
| BioVie Inc. | 9.7 Million USD | -2698.681% |
| Codexis, Inc. | 49.94 Million USD | -443.651% |
| Celularity Inc. | 102.92 Million USD | -163.805% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -141.578% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -182.12% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -78560.604% |
| Cibus, Inc. | 206.11 Million USD | -31.737% |
| IN8bio, Inc. | 8.77 Million USD | -2995.436% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -203.248% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -1883.576% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | 89.57% |
| Eyenovia, Inc. | 19.78 Million USD | -1272.739% |
| Puma Biotechnology, Inc. | 177.08 Million USD | -53.333% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -3435.109% |
| Elevation Oncology, Inc. | 34.28 Million USD | -692.053% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -1026.734% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -2182.162% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | -10.586% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -2739.399% |
| Moolec Science SA | 13.94 Million USD | -1847.112% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -529.245% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -437.346% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -582.652% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -3156.947% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -92130.35% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -10936.608% |
| Humacyte, Inc. | 114.67 Million USD | -136.78% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -926.081% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -22603.318% |
| Genelux Corporation | 8.42 Million USD | -3124.842% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -3860.497% |
| Notable Labs, Ltd. | 4.42 Million USD | -6033.537% |
| Immunovant, Inc. | 48.95 Million USD | -454.656% |
| Quantum-Si incorporated | 26.63 Million USD | -919.608% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -8650.618% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -267.625% |
| Acasti Pharma Inc. | 11.55 Million USD | -2249.5% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -1101.057% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -1071.203% |
| PepGen Inc. | 34.63 Million USD | -684.071% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -3787.911% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -3073.14% |
| Immuneering Corporation | 12 Million USD | -2161.19% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -86414.183% |
| Belite Bio, Inc | 4.21 Million USD | -6348.152% |
| XOMA Corporation | 145.58 Million USD | -86.517% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -11083.348% |
| Bionomics Limited | 10.15 Million USD | -2572.892% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -1085.055% |
| uniQure N.V. | 624.01 Million USD | 56.487% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -150165.735% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -59.552% |
| Forte Biosciences, Inc. | 3.66 Million USD | -7306.756% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -104101.611% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -3924.48% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -3435.109% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -1462.053% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -2469.376% |
| Altimmune, Inc. | 16.54 Million USD | -1541.568% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -5471.023% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -1085.055% |
| Peak Bio, Inc. | 20.75 Million USD | -1208.374% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -145.812% |
| Benitec Biopharma Inc. | 4.96 Million USD | -5372.223% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -72.026% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -261.204% |
| Zura Bio Limited | 21.29 Million USD | -1175.276% |
| PolyPid Ltd. | 17.46 Million USD | -1454.452% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -261.204% |
| argenx SE | 444.95 Million USD | 38.975% |
| Immunome, Inc. | 28.65 Million USD | -847.49% |
| Verona Pharma plc | 58.84 Million USD | -361.467% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -1776.126% |
| Shattuck Labs, Inc. | 14.85 Million USD | -1727.389% |
| CervoMed Inc. | 2.59 Million USD | -10360.638% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -2032.001% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -2477.425% |
| Moolec Science SA | 13.94 Million USD | -1847.112% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -11486.568% |
| Design Therapeutics, Inc. | 11.95 Million USD | -2171.091% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -2040.742% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -597.523% |
| Achilles Therapeutics plc | 19.08 Million USD | -1322.6% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -1093.036% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -1771.213% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | 32.333% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -736.177% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -1980.847% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -5069.078% |
| Beam Therapeutics Inc. | 478.38 Million USD | 43.24% |
| Mirum Pharmaceuticals, Inc. | 397.95 Million USD | 31.768% |
| AEON Biopharma, Inc. | 159.88 Million USD | -69.825% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -897.252% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -945.922% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -3471.744% |
| NeurAxis, Inc. | 1.91 Million USD | -14095.961% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | -38.722% |
| Lumos Pharma, Inc. | 13.33 Million USD | -1936.539% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -1051.144% |
| Palisade Bio, Inc. | 2.73 Million USD | -9813.534% |
| Nutriband Inc. | 1.07 Million USD | -25067.013% |
| Taysha Gene Therapies, Inc. | 192.05 Million USD | -41.381% |
| Neurogene Inc. | 36.54 Million USD | -642.925% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -11005.59% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -469.846% |
| Athira Pharma, Inc. | 30.05 Million USD | -803.389% |
| HCW Biologics Inc. | 15.05 Million USD | -1703.964% |
| XOMA Corporation | 145.58 Million USD | -86.517% |
| Nektar Therapeutics | 267.04 Million USD | -1.68% |
| Arvinas, Inc. | 644.6 Million USD | 57.876% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -1431.211% |
| Merus N.V. | 102.15 Million USD | -165.814% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -85.536% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -185.462% |
| Rezolute, Inc. | 11.73 Million USD | -2214.059% |
| Clene Inc. | 38.95 Million USD | -597.111% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -9436.194% |
| BeyondSpring Inc. | 48.26 Million USD | -462.538% |
| Synlogic, Inc. | 32.89 Million USD | -725.45% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -1758.152% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -16517.606% |
| Peak Bio, Inc. | 20.75 Million USD | -1208.374% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -327.885% |
| Krystal Biotech, Inc. | 39.71 Million USD | -583.718% |
| Karyopharm Therapeutics Inc. | 376.64 Million USD | 27.908% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -172.707% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -62649.103% |
| MannKind Corporation | 721.36 Million USD | 62.359% |
| Ikena Oncology, Inc. | 22.33 Million USD | -1115.723% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -12916.859% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -164.677% |
| Gossamer Bio, Inc. | 249.14 Million USD | -8.985% |
| CohBar, Inc. | 1.03 Million USD | -26169.515% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -2440.291% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -1325.513% |
| Legend Biotech Corporation | 589.93 Million USD | 53.972% |
| Mural Oncology plc | 37.92 Million USD | -615.914% |
| Disc Medicine, Inc. | 22.87 Million USD | -1087.024% |
| Champions Oncology, Inc. | 28.03 Million USD | -868.545% |
| REGENXBIO Inc. | 262.22 Million USD | -3.548% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -7982.859% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -2066.361% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -1921.584% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -1180.508% |
| Vaxart, Inc. | 34.02 Million USD | -698.036% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -1231.739% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -851.678% |
| Cellectis S.A. | 249.57 Million USD | -8.798% |
| Longeveron Inc. | 5.33 Million USD | -4987.721% |
| Repare Therapeutics Inc. | 41.81 Million USD | -549.302% |
| Sarepta Therapeutics, Inc. | 2.4 Billion USD | 88.711% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -349.794% |
| Revolution Medicines, Inc. | 262.39 Million USD | -3.481% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -12787.123% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -3047.828% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -2200.921% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -1833.573% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -12523.509% |
| Vertex Pharmaceuticals Incorporated | 5.14 Billion USD | 94.727% |
| Denali Therapeutics Inc. | 122.96 Million USD | -120.824% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -4779.369% |
| Veru Inc. | 32.81 Million USD | -727.52% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -3853.002% |
| Cingulate Inc. | 10.36 Million USD | -2520.743% |
| Passage Bio, Inc. | 39.26 Million USD | -591.589% |
| Context Therapeutics Inc. | 4.19 Million USD | -6377.818% |
| Exicure, Inc. | 8.54 Million USD | -3076.181% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -820.197% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -2489.469% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -1131.939% |
| Nuvalent, Inc. | 31.82 Million USD | -753.256% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -4168.274% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -330.852% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -1408.509% |
| OmniAb, Inc. | 87.4 Million USD | -210.677% |
| Anew Medical, Inc. | 8.24 Million USD | -3194.568% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -609.162% |
| Lipocine Inc. | 2.63 Million USD | -10218.008% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -933.54% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -575.25% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -919.194% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -215.17% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -4927.434% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -228.147% |
| Ocugen, Inc. | 23.98 Million USD | -1032.184% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -485.109% |
| Q32 Bio Inc. | 233.12 Million USD | -16.473% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -2895.055% |
| Alumis Inc. Common Stock | 53.5 Million USD | -407.517% |
| Equillium, Inc. | 27.95 Million USD | -871.248% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | -31.434% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -4725.802% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -4327.411% |
| Dominari Holdings Inc. | 4.63 Million USD | -5758.289% |
| Edesa Biotech, Inc. | 1.84 Million USD | -14644.039% |
| vTv Therapeutics Inc. | 29.56 Million USD | -818.361% |
| Bio-Techne Corporation | 744.34 Million USD | 63.52% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -115.332% |
| Harmony Biosciences Holdings, Inc. | 344.45 Million USD | 21.171% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -569.209% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -837.707% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -193.993% |
| Nkarta, Inc. | 105.6 Million USD | -157.132% |
| BioCardia, Inc. | 4.59 Million USD | -5815.723% |
| Iterum Therapeutics plc | 32.66 Million USD | -731.338% |